| Obstetrics and Gynecology | Lifetime | 49 | US 18 | 99.65 |
| Reproductive Medicine | Lifetime | 165 | US 81 | 99.11 |
| Obstetrics and Gynecology | 2021-2025 | 167 | US 53 | 94.93 |
| Reproductive Medicine | 2021-2025 | 257 | US 82 | 85.82 |
| Rheumatology | 2021-2025 | 409 | US 131 | 81.76 |
| Uterine Myomas and Treatments | Lifetime | 14 | US 4 | 99.77 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 47 | US 24 | 99.62 |
| Ovarian cancer diagnosis and treatment | Lifetime | 61 | US 36 | 99.59 |
| Sarcoma Diagnosis and Treatment | Lifetime | 105 | US 52 | 99.46 |
| Urinary and Genital Oncology Studies | Lifetime | 184 | US 107 | 98.71 |
| Urologic and reproductive health conditions | Lifetime | 252 | US 138 | 98.38 |
| Chromatin Remodeling and Cancer | Lifetime | 96 | US 54 | 97.26 |
| Gestational Trophoblastic Disease Studies | Lifetime | 69 | US 32 | 97.04 |
| Renal and related cancers | Lifetime | 541 | US 277 | 97.54 |
| Tuberous Sclerosis Complex Research | Lifetime | 69 | US 43 | 96.58 |
| Renal cell carcinoma treatment | Lifetime | 764 | US 389 | 97.06 |
| Cervical Cancer and HPV Research | Lifetime | 855 | US 364 | 96.64 |
| Testicular diseases and treatments | Lifetime | 357 | US 151 | 96.39 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 939 | US 404 | 96.76 |
| Endometriosis Research and Treatment | Lifetime | 828 | US 246 | 96.20 |
| Cancer Mechanisms and Therapy | Lifetime | 653 | US 260 | 94.03 |
| Soft tissue tumor case studies | Lifetime | 393 | US 208 | 94.94 |
| Vascular Tumors and Angiosarcomas | Lifetime | 468 | US 238 | 94.59 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 934 | US 339 | 90.89 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 486 | US 115 | 87.61 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 168 | US 42 | 97.07 |
| Cervical Cancer and HPV Research | 2021-2025 | 266 | US 85 | 94.38 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 337 | US 100 | 95.04 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 439 | US 167 | 92.71 |
| Uterine Myomas and Treatments | 2021-2025 | 248 | US 50 | 92.99 |
| Urologic and reproductive health conditions | 2021-2025 | 277 | US 62 | 87.15 |
| Soft tissue tumor case studies | 2021-2025 | 131 | US 49 | 82.64 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 147 | US 26 | 78.36 |
| Cancer and Skin Lesions | 2021-2025 | 448 | US 142 | 75.41 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 295 | US 113 | 60.08 |
